Close Menu
healthlifestylee.blog

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Ryan ‘Koup’ Kuperus Shares How the Reason Outdoors is Saving Lives and Building a Community

    November 21, 2026

    Try This ‘GTA6’ Workout to Power Up Your Player

    November 21, 2026

    Hany Rambod Shares His Top Rule For Building Wider Shoulders

    November 21, 2026
    Facebook X (Twitter) Instagram
    Trending
    • Ryan ‘Koup’ Kuperus Shares How the Reason Outdoors is Saving Lives and Building a Community
    • Try This ‘GTA6’ Workout to Power Up Your Player
    • Hany Rambod Shares His Top Rule For Building Wider Shoulders
    • Andrew Jacked Shares His Back-Building Training Ahead of the Arnold Classic
    • Why do farts smell so bad? The secret is brewing in your gut
    • Too much exercise could leave your brain stuck in overdrive
    • A study of 30,000 people reveals which antidepressants may work best
    • Powerful new weight-loss drug helps patients cut knee pain in half
    Facebook X (Twitter) Instagram Pinterest
    healthlifestylee.blog
    • Home
    • Health
    • Fitness
    • Lifestyle
    • Wellness
    • Nutrition
    • Healthy Living
    • Mental Health
    • Beauty & Self-Care
    healthlifestylee.blog
    Home»Mental Health»A study of 30,000 people reveals which antidepressants may work best
    Mental Health

    A study of 30,000 people reveals which antidepressants may work best

    everyonehub2025@gmail.comBy everyonehub2025@gmail.comNovember 21, 2026No Comments6 Mins Read0 Views
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    A study of 30,000 people reveals which antidepressants may work best
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Date:
    November 19, 2026 30,000 people found that three antidepressants, including Lexapro and Cymbalta, may be more effective than Prozac at maintaining improvements in depression symptoms. However, limitations in the research and a lack of truly long-term data mean scientists still cannot say which antidepressant is best.
    Share:
    FULL STORY

    A new review has found some antidepressants may be more effective than others at helping people reduce the severity of their symptoms of depression over the long term.

    The research, published in The Lancet Psychiatry, found people taking escitalopram (commonly sold as Lexapro), duloxetine (Cymbalta) and agomelatine (Valdoxan) were more likely to report improved symptoms over the long term than those taking fluoxetine (Prozac). For those taking Lexapro and Cymbalta, they were also more likely to stay on their medications.

    But does that mean these are the best antidepressants?

    Why do people take antidepressants long term?

    Around one in seven Australians will experience depression during their lifetime.

    Treatment can involve psychological therapies, social support and lifestyle changes, such as doing more exercise. For some people, these approaches may be enough to support recovery. For others, adding an antidepressant can be an important part of treatment.

    In 2024-2025, 3.8 million Australians were dispensed a prescription for an antidepressant.

    For adults with depression, clinical guidelines recommend continuing antidepressants for at least six months, and preferably 12 months, after an acceptable response to treatment is achieved.

    If, after six to 12 months, the depressive episode has resolved, it may be appropriate to reduce, and eventually stop the antidepressant. But symptoms can occur when discontinuing antidepressants so it’s important this is done gradually, in consultation with a doctor.

    Studies of real world antidepressant prescribing patterns in Australia suggest many people take antidepressants for longer than this. One 2022 study found nearly a quarter of those prescribed antidepressants were still receiving prescriptions for them two years later.

    Another Australian study found people take antidepressants for an average of four years.

    What did the researchers find?

    The new review set out to compare how well different antidepressants help people maintain improvements in depression. The researchers also compared how acceptable the medicines were to the people taking them. They measured this by looking at the proportion of people who stopped treatment for any reason during the study period.

    The researchers identified and reviewed 115 randomized controlled trials, involving more than 30,000 people. The researchers classified long-term use as six months or more. Their main analysis combined the results of 35 trials that directly compared one antidepressant with another.

    They found that three antidepressants – escitalopram, duloxetine and agomelatine – were associated with a greater likelihood of sustained response than fluoxetine.

    People taking escitalopram or duloxetine were also less likely to drop out of the trials than those taking fluoxetine.

    How reliable are the findings?

    The findings are interesting as escitalopram (Lexapro) is the most commonly prescribed antidepressant in Australia. It ranked number 13 out of all PBS-dispensed prescriptions in 2024–25. Duloxetine was number 45, but agomelatine isn’t available on the PBS.

    The findings suggest some antidepressants may be more effective than others at sustaining a response to treatment, but the results are far from definitive. More than half of the studies included in the main analysis were assessed as having a high risk of bias.

    This means some of the differences between antidepressants may reflect limitations in the original studies rather than genuine differences between the medicines. Some medicines were also supported by very few studies, making comparisons less certain.

    Another aspect to keep in mind when considering these results is what is meant by “long term.” The trials directly comparing antidepressants typically followed participants for around six months after they first started taking the medication. Only six followed people for longer than six months.

    This means we still know relatively little about how the effectiveness of different antidepressants compares over longer periods. This is important given the average time people take them is much longer.

    What this research can’t tell us

    Importantly, these findings reflect average outcomes across groups of people. They can’t tell us which antidepressant will work best for any particular person.

    People respond differently to antidepressants, and what makes a medicine acceptable to one person may not be acceptable to another. While the researchers used trial drop-out rates as a measure of acceptability, this doesn’t necessarily capture people’s experiences of taking these medicines.

    For someone taking an antidepressant, acceptability might not be so binary. It may involve a trade-off between how the medication improves symptoms, its side effects, and how the medicine affects their everyday life.

    Continuing to take an antidepressant doesn’t necessarily mean someone finds it acceptable. Some people experience withdrawal symptoms when trying to stop, which can make discontinuation difficult.

    What’s the best fit for you?

    Ultimately, determining if an antidepressant is right for you, and which is the best fit, depends on many factors. These include your symptoms, other health conditions, previous experiences with medicines, potential side effects and what matters most to you.

    If you’re taking an antidepressant that’s working well for you, the findings of this study aren’t a reason to switch.

    And if you’re considering starting, changing or stopping an antidepressant, discuss your options with your doctor.

    Materials provided by The Conversation. Original Note: Content may be edited for style and length

    1. Paul C F van Haaren, Jakob M van Gaalen, Edoardo G Ostinelli, Kiyomi Shinohara, Aran Tajika, Rosario Aronica, Nobuatsu Aoki, Eduarda Batista, Suzanne A Ligthart, Christiaan H Vinkers, Orestis Efthimiou, Andrea Cipriani, Toshi A Furukawa, Henricus G Ruhé. Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depressive disorder: a systematic review and network meta-analysis. The Lancet Psychiatry, 2026; DOI: 10.1016/S2215-0366(26)00326-3

    The Conversation. “A study of 30,000 people reveals which antidepressants may work best.” ScienceDaily. ScienceDaily, 19 November 2026. <www.sciencedaily.com/releases/2026/11/261118065515.htm>.
    The Conversation. (2026, November 19). A study of 30,000 people reveals which antidepressants may work best. ScienceDaily. Retrieved November 20, 2026 from www.sciencedaily.com/releases/2026/11/261118065515.htm
    The Conversation. “A study of 30,000 people reveals which antidepressants may work best.” ScienceDaily. www.sciencedaily.com/releases/2026/11/261118065515.htm (accessed November 20, 2026).

    RELATED STORIES

    30000 People reveals Study Which
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    everyonehub2025@gmail.com
    • Website

    Related Posts

    Mental Health

    Why do farts smell so bad? The secret is brewing in your gut

    November 21, 2026
    Mental Health

    Too much exercise could leave your brain stuck in overdrive

    November 21, 2026
    Mental Health

    Powerful new weight-loss drug helps patients cut knee pain in half

    November 21, 2026
    Mental Health

    Is free will an illusion? New brain research reveals a surprising twist

    November 20, 2026
    Mental Health

    Scientists discover a hidden hereditary form of aggressive prostate cancer

    November 20, 2026
    Mental Health

    Why don't weight-loss drugs like Ozempic and Wegovy work for everyone?

    November 20, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Subscribe to News

    Get the latest sports news from NewsSite about world, sports and politics.

    Health

    Ryan ‘Koup’ Kuperus Shares How the Reason Outdoors is Saving Lives and Building a Community

    November 21, 2026

    Try This ‘GTA6’ Workout to Power Up Your Player

    November 21, 2026

    Hany Rambod Shares His Top Rule For Building Wider Shoulders

    November 21, 2026

    Andrew Jacked Shares His Back-Building Training Ahead of the Arnold Classic

    November 21, 2026
    Latest Posts

    Steps to support mental health for rural youth

    September 18, 2026

    The Most-Saved Recipes on Bon Appétit This Week

    September 18, 2026

    This Dual-Voltage Hair Dryer Is Actually Lightweight and Compact Enough to Pack

    September 18, 2026
    About us

    Welcome to HealthLifestylee.blog, your trusted destination for health, wellness, and lifestyle information designed to help you make more informed decisions and live a healthier, more balanced life.

    Our mission is simple: to provide clear, useful, and engaging content that supports your everyday well-being. From health and nutrition to fitness, mental wellness, beauty, and healthy living, we bring together practical insights and informative articles covering the topics that matter most to your lifestyle.

    Facebook X (Twitter) Instagram Pinterest YouTube

    Ryan ‘Koup’ Kuperus Shares How the Reason Outdoors is Saving Lives and Building a Community

    November 21, 2026

    Try This ‘GTA6’ Workout to Power Up Your Player

    November 21, 2026

    Hany Rambod Shares His Top Rule For Building Wider Shoulders

    November 21, 2026

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Contact us
    • Disclaimer
    • Privacy Policy
    • Terms and Conditions
    © 2026 healthlifestylee.blog. Designed by Pro.

    Type above and press Enter to search. Press Esc to cancel.